The application discloses novel polymorphic crystalline forms of 2-[4-Bromo-3-(3-chloro- 5-cyano-phenoxy)-2-fluoro-phenyl]-N-(2-chloro-4-propionylsulfamoyl-phenyl)-acetamide, sodium salt (Ib) with improved stability and physical properties which facilitate manufacturing, handling and formulating for treatment or prophylaxis of HIV mediated diseases, AIDS or ARC, in monotherapy or in combination therapy.
申请公布号
WO2010028968(A3)
申请公布日期
2010.06.10
申请号
WO2009EP61185
申请日期
2009.08.31
申请人
F. HOFFMANN-LA ROCHE AG;DAVIDSON, JAMES PRENTICE;MARTIN, MICHAEL;PANG, FEI;WONG, MARGARET
发明人
DAVIDSON, JAMES PRENTICE;MARTIN, MICHAEL;PANG, FEI;WONG, MARGARET